EUVIMEDEUVIMED entdecken
Crossref

ROS‐Responsive Micellar Delivery of Bergapten for Coordinated Attenuation of Oxidative Stress and Neuroinflammation in Neonatal Hypoxic‐Ischemic Brain Damage

Rengcheng Qian iD, Xiaoli Chen, Yingying Pan, Xinyi Wang, Zhenlang Lin iD, Huaqiong Li iD, Dejun Yang iD

Small · 2026-11 · 22 (63)

DOI: 10.1002/smll.76559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 31.10.2026. Verfasst von Rengcheng Qian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Soft Matter Biomedical Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Oxidative Stress, Hypoxia-Ischemia, Brain, Reactive Oxygen Species, Micelles. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Wenzhou Municipal Basic Scientific Research Project, University of Chinese Academy of Sciences, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neonatal hypoxic‐ischemic brain damage (HIBD) represents a leading contributor to neonatal death and persistent neurological impairments, yet effective therapeutic options beyond hypothermia remain limited. Excessive reactive oxygen species (ROS) production and Toll‐like receptor (TLR)‐mediated neuroinflammation contribute to neuronal loss during hypoxic‐ischemic injury. Here, a ROS‐responsive antioxidant nanomicellar system (BGT@NPEP) based on an NPEP‐PEG‐PPG (NPEP) platform is reported for targeted delivery of the anti‐inflammatory coumarin bergapten (BGT) to ischemic neonatal brain tissue. The nanomicelles incorporate ROS‐cleavable boronate ester‐linked nordihydroguaiaretic acid, conferring intrinsic antioxidant activity and stimulus‐responsive drug release, while a neutral, size‐controlled shell facilitates accumulation in the ischemic hemisphere. The therapeutic efficacy of BGT@NPEP was systematically evaluated in vitro using oxygen‐glucose deprivation models and in vivo in neonatal HIBD models. Mechanistic investigations indicate that BGT@NPEP significantly reduced oxidative stress, enhanced glutathione peroxidase 1 (GPX1) activity, suppressed TLR‐driven inflammatory signaling, and modulated microglial polarization by inhibiting the M1 phenotype and promoting M2 phenotype transition. These effects collectively attenuated neuronal injury, reduced infarct volume, and improved neurological outcomes. Overall, this study demonstrates a dual‐action, ROS‐responsive nanotherapeutic strategy that integrates redox regulation with targeted anti‐inflammatory delivery, providing a promising minimally invasive approach for neuroprotection in neonatal HIBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressHypoxia-Ischemia, BrainReactive Oxygen SpeciesMicellesNeuroinflammatory DiseasesAnimalsAnimals, NewbornAntioxidantsNanoparticles

Stichwörter der Autor:innen

antioxidantanti‐inflammatoryhypoxic‐ischemic brain damagenanomicelle‐based drug deliveryneuroprotection

Substanzen

Reactive Oxygen SpeciesMicellesAntioxidants

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Soft Matter Biomedical Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, China.
  • Department of Pediatrics, the Second School of Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Key Laboratory of Perinatal Medicine of Wenzhou, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • School of Nursing, Wenzhou Medical University, Wenzhou, Zhejiang, China.

ORCID-Profile: Rengcheng Qian, Zhenlang Lin, Huaqiong Li, Dejun Yang

Förderung

  • Wenzhou Municipal Basic Scientific Research Project
  • University of Chinese Academy of Sciences
  • National Natural Science Foundation of China
  • Zhejiang Provincial Natural Science Foundation of China
  • Zhejiang Key Laboratory of Soft Matter Biomedical Materials
  • Zhejiang Provincial Special Fund for Scientific and Technological Development

Zitieren

APA

Qian, R., Chen, X., Pan, Y., Wang, X., Lin, Z., Li, H., & Yang, D. (2026). ROS‐Responsive Micellar Delivery of Bergapten for Coordinated Attenuation of Oxidative Stress and Neuroinflammation in Neonatal Hypoxic‐Ischemic Brain Damage. Small, 22(63). https://doi.org/10.1002/smll.76559

Vancouver

Qian R, Chen X, Pan Y, Wang X, Lin Z, Li H, et al. ROS‐Responsive Micellar Delivery of Bergapten for Coordinated Attenuation of Oxidative Stress and Neuroinflammation in Neonatal Hypoxic‐Ischemic Brain Damage. Small. 2026;22(63). doi:10.1002/smll.76559

BibTeX
@article{Qian2026,
  author = {Qian, Rengcheng and Chen, Xiaoli and Pan, Yingying and Wang, Xinyi and Lin, Zhenlang and Li, Huaqiong and Yang, Dejun},
  title = {ROS‐Responsive Micellar Delivery of Bergapten for Coordinated Attenuation of Oxidative Stress and Neuroinflammation in Neonatal Hypoxic‐Ischemic Brain Damage},
  journal = {Small},
  year = {2026},
  volume = {22},
  number = {63},
  doi = {10.1002/smll.76559}
}
Kostenlos starten →